RxSight, Inc.

Q2 2022 vs. Q1 2025 13F Holders

Period
Q2 2022
Q1 2025
Num holders
50
201
Total reported value, excl. options
$131 M
$924 M
Total shares, excl. options
9,305,973
36,595,902
Manager Q2 2022
Shares 		Q1 2025
Shares 		Diff Chg %